68727-900Level 3
Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn)
**Product type:** Human Prescription Drug
**Active ingredient:** ASPARAGINASE
**Strength:** 20 mg/mL
**Dosage form:** Injection
**Route:** Intramuscular
**Labeler:** Jazz Pharmaceuticals, Inc.
**Marketing category:** BLA (BLA761179)
**Pharmacologic class:** Asparaginase [CS], Asparagine-specific Enzyme [EPC]
GET
/api/v1/systems/ndc_fda/nodes/68727-900Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.